
Thynk Capital
North America, Nevada, United States, Las Vegas
Description
Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.
Investor Profile
Thynk Capital has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 6% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Convertible Note, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Convertible Note (31%)
- Series A (31%)
- Seed (25%)
- Post Ipo Equity (6%)
- Series Unknown (6%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Biopharma
- Manufacturing
- Medical Device
- Automotive
- Electric Vehicle
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.